{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T11:20:15Z","timestamp":1777029615203,"version":"3.51.4"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Adv Skin Wound Care"],"published-print":{"date-parts":[[2021,4]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:sec>\n            <jats:title>OBJECTIVE<\/jats:title>\n            <jats:p>To discuss human amnion chorion (placental) membrane allograft (HACMA) use for the treatment of chronic diabetic foot ulcers (DFUs) and to evaluate the effectiveness, cost, and product waste of this therapy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>DATA SOURCES<\/jats:title>\n            <jats:p>PubMed, Cochrane, and OVID databases.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>STUDY SELECTION<\/jats:title>\n            <jats:p>Twenty-four articles pertaining to HACMA and DFUs published from 2016 to 2020 were selected.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>DATA EXTRACTION<\/jats:title>\n            <jats:p>The data collected included type of wound care product, study design, study size, baseline size of DFU, cost, product wastage, number of applications, and wound healing outcomes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>DATA SYNTHESIS<\/jats:title>\n            <jats:p>Human amnion chorion membrane allografts in the treatment of chronic DFUs have led to a reduction in healing time and increased the overall percentage of healing, making them more effective in treating DFUs compared with standard of care. These products are offered in multiple sizes with various shelf lives and methods of storage, making them accessible, easy to use, less wasteful, and lower in cost compared with other commercially available products. Promising evidence demonstrates that HACMAs are beneficial in treating complex, high-grade DFUs with exposed tendon or bone.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSIONS<\/jats:title>\n            <jats:p>Human amnion chorion membrane allografts are effective in treating chronic DFUs with a greater percentage of complete wound closure and a reduction in healing time versus standard of care.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/01.asw.0000734388.08779.e8","type":"journal-article","created":{"date-parts":[[2021,3,19]],"date-time":"2021-03-19T19:05:02Z","timestamp":1616180702000},"page":"1-7","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Human Amnion Chorion Membrane Allografts in the Treatment of Chronic Diabetic Foot Ulcers: A Literature Review"],"prefix":"10.1097","volume":"34","author":[{"given":"Alisha","family":"Oropallo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashley","family":"Goodwin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MaKenzie","family":"Morrissey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Del Pin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amit","family":"Rao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"issue":"2","key":"bib2-20250615","first-page":"106","article-title":"Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis","volume":"49","year":"2016","journal-title":"Ann Med"},{"key":"bib3-20250615","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1056\/NEJMra1615439","article-title":"Diabetic Foot ulcers and their recurrence","volume":"376","year":"2017","journal-title":"N Engl J Med"},{"issue":"11","key":"bib4-20250615","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1111\/dme.13054","article-title":"Association of diabetic foot ulcer and death in a population-based cohort from the United Kingdom","volume":"33","year":"2016","journal-title":"Diabet Med"},{"issue":"1","key":"bib5-20250615","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/nyas.13569","article-title":"Update on management of diabetic foot ulcers","volume":"1411","year":"2018","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"bib7-20250615","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/iwj.12566","article-title":"Treatment of chronic diabetic lower extremity ulcers with advanced therapies: a prospective, randomised, controlled, multi-centre comparative study examining clinical efficacy and cost","volume":"13","year":"2016","journal-title":"Int Wound J"},{"issue":"3","key":"bib8-20250615","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/iwj.12649","article-title":"A prospective, multicentre, open-label, single-arm clinical trial for treatment of chronic complex diabetic foot wounds with exposed tendon and\/or bone: positive clinical outcomes of viable cryopreserved human placental membrane","volume":"14","year":"2017","journal-title":"Int Wound J"},{"issue":"5","key":"bib9-20250615","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1007\/s13300-017-0298-8","article-title":"Efficacy and time sensitivity of amniotic membrane treatment in patients with diabetic foot ulcers: a systematic review and meta-analysis","volume":"8","year":"2017","journal-title":"Diabetes Ther"},{"issue":"8","key":"bib10-20250615","doi-asserted-by":"crossref","first-page":"e2371","DOI":"10.1097\/GOX.0000000000002371","article-title":"Placental membrane provides improved healing efficacy and lower cost versus a tissue-engineered human skin in the treatment of diabetic foot ulcerations","volume":"7","year":"2019","journal-title":"Plast Reconstr Surg Glob Open"},{"issue":"6","key":"bib11-20250615","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1111\/iwj.12954","article-title":"Use of an aseptically processed, dehydrated human amnion and chorion membrane improves likelihood and rate of healing in chronic diabetic foot ulcers: a prospective, randomised, multi-centre clinical trial in 80 patients","volume":"15","year":"2018","journal-title":"Int Wound J"},{"issue":"1","key":"bib12-20250615","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/wrr.12503","article-title":"A comparative outcomes analysis evaluating clinical effectiveness in two different human placental membrane products for wound management","volume":"25","year":"2017","journal-title":"Wound Repair Regen"},{"issue":"4Suppl","key":"bib13-20250615","first-page":"S19","article-title":"Clinical experiences using a dehydrated amnion\/chorion membrane construct for the management of wounds","volume":"31","year":"2019","journal-title":"Wounds"},{"issue":"2","key":"bib14-20250615","doi-asserted-by":"crossref","first-page":"84","DOI":"10.7547\/17-039","article-title":"Use of dehydrated human amnion\/chorion membrane allografts in more than 100 patients with six major types of refractory nonhealing wounds","volume":"108","year":"2018","journal-title":"J Am Podiatr Med Assoc"},{"issue":"14","key":"bib15-20250615","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.2217\/cer-2019-0001","article-title":"Comparative effectiveness of a human fibroblast-derived dermal substitute and a viable cryopreserved placental membrane for the treatment of diabetic foot ulcers","volume":"8","year":"2019","journal-title":"J Comp Eff Res"},{"issue":"2","key":"bib16-20250615","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/wrr.12635","article-title":"Effectiveness of viable cryopreserved placental membranes for management of diabetic foot ulcers in a real world setting","volume":"26","year":"2018","journal-title":"Wound Repair Regen"},{"issue":"3","key":"bib17-20250615","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/wrr.12645","article-title":"A multicenter, randomized, single-blind trial comparing the efficacy of viable cryopreserved placental membrane to human fibroblast-derived dermal substitute for the treatment of chronic diabetic foot ulcers","volume":"26","year":"2018","journal-title":"Wound Repair Regen"},{"issue":"5","key":"bib18-20250615","doi-asserted-by":"crossref","first-page":"328","DOI":"10.7547\/15-139","article-title":"A retrospective case series of a dehydrated amniotic membrane allograft for treatment of unresolved diabetic foot ulcers","volume":"106","year":"2016","journal-title":"J Am Podiatr Med Assoc"},{"issue":"Sup7","key":"bib19-20250615","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.12968\/jowc.2016.25.7.S4","article-title":"Treatment of diabetic foot ulcers with dehydrated amniotic membrane allograft: a prospective case series","volume":"25","year":"2016","journal-title":"J Wound Care"},{"issue":"10","key":"bib20-20250615","doi-asserted-by":"crossref","first-page":"e1095","DOI":"10.1097\/GOX.0000000000001095","article-title":"Aseptically processed placental membrane improves healing of diabetic foot ulcerations: prospective, randomized clinical trial","volume":"4","year":"2016","journal-title":"Plast Reconstr Surg Glob Open"},{"issue":"1","key":"bib21-20250615","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/iwj.12976","article-title":"A confirmatory study on the efficacy of dehydrated human amnion\/chorion membrane dHACM allograft in the management of diabetic foot ulcers: a prospective, multicentre, randomised, controlled study of 110 patients from 14 wound clinics","volume":"16","year":"2019","journal-title":"Int Wound J"},{"issue":"1","key":"bib22-20250615","first-page":"122","article-title":"A multicentre prospective randomised controlled comparative parallel study of dehydrated human umbilical cord (EpiCord) allograft for the treatment of diabetic foot ulcers","volume":"16","year":"2018","journal-title":"Int Wound J"},{"issue":"4","key":"bib23-20250615","doi-asserted-by":"crossref","first-page":"e1302","DOI":"10.1097\/GOX.0000000000001302","article-title":"Amnion membrane in diabetic foot wounds: a meta-analysis","volume":"5","year":"2017","journal-title":"Plast Reconstr Surg Glob Open"},{"issue":"5","key":"bib24-20250615","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/iwj.12715","article-title":"Safety and efficacy of intramuscular human placenta-derived mesenchymal stromal-like cells (cenplacel [PDA-002]) in patients who have a diabetic foot ulcer with peripheral arterial disease","volume":"14","year":"2017","journal-title":"Int Wound J"},{"issue":"1","key":"bib25-20250615","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2217\/cer-2019-0142","article-title":"A randomized controlled clinical trial of a hypothermically stored amniotic membrane for use in diabetic foot ulcers","volume":"9","year":"2020","journal-title":"J Comp Eff Res"},{"key":"bib26-20250615","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/01.ASW.0000557831.78645.85","article-title":"Comparing human amniotic allograft and standard wound care when using total contact casting in the treatment of patients with diabetic foot ulcers","volume":"32","year":"2019","journal-title":"Adv Skin Wound Care"},{"issue":"10","key":"bib27-20250615","first-page":"311","article-title":"A retrospective crossover study of the use of aseptically processed placental membrane in the treatment of chronic diabetic foot ulcers","volume":"29","year":"2017","journal-title":"Wounds"},{"issue":"11","key":"bib28-20250615","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1089\/wound.2019.1028","article-title":"Wound closure outcomes suggest clinical equivalency between lyopreserved and cryopreserved placental membranes containing viable cells","volume":"8","year":"2019","journal-title":"Adv Wound Care (New Rochelle)"},{"issue":"6","key":"bib29-20250615","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1111\/wrr.12754","article-title":"An open-label trial of cryopreserved human umbilical cord in the treatment of complex diabetic foot ulcers complicated by osteomyelitis","volume":"27","year":"2019","journal-title":"Wound Repair Regen"},{"key":"bib30-20250615","first-page":"70","article-title":"A prospective, randomized, multicenter, controlled evaluation of the use of dehydrated amniotic membrane allograft compared to standard of care for the closure of chronic diabetic foot ulcer","volume":"28","year":"2016","journal-title":"Wounds"},{"issue":"7 Suppl","key":"bib31-20250615","first-page":"239S","article-title":"Percent change in wound area of diabetic foot ulcers over a 4-week period is a robust predictor of complete healing in a 12-week prospective trial","volume":"117","year":"2006","journal-title":"Plast Reconstr Surg"},{"issue":"9","key":"bib33-20250615","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1089\/wound.2015.0634","article-title":"Use of placental membranes for the treatment of chronic diabetic foot ulcers","volume":"4","year":"2015","journal-title":"Adv Wound Care (New Rochelle)"}],"container-title":["Advances in Skin &amp; Wound Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/01.ASW.0000734388.08779.e8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T21:05:37Z","timestamp":1750021537000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/01.ASW.0000734388.08779.e8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/01.asw.0000734388.08779.e8","relation":{},"ISSN":["1538-8654","1527-7941"],"issn-type":[{"value":"1538-8654","type":"electronic"},{"value":"1527-7941","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]}}}